Avia Parma makes its third acquisition in 2022

Avia Pharma has today completed the acquisition of Unimedic’s Vitamin D oil. “The acquisition is in line with Avia Pharma’s strategy to own more products and will complement our existing portfolio”, says Jacob Calmvik, CEO of Avia Pharma. For further information, please contact Jacob Calmvik, CEO Avia Pharma, jacob.calmvik@aviapharma.se, +46 703

Read More

Avia Pharma expands into Germany

Avia Pharma has today completed the acquisition of Allergika Pharma GmbH. The company has a turnover of close to 15 million EUR and is placed in Wolfratshausen, near Munich. Allergika is a German pharmaceutical company focused on the allergy market. It sells both dermatology products and encasing under its own

Read More

Avia Pharma acquires Decem Pharma

Avia Pharma has today completed the acquisition of Decem Pharma. Decem Pharma is a Finish pharmaceutical company with its own brands with strong market positions, such as Magnecit and Otocur. The acquisition of Decem Pharma is Avia Pharma’s first acquisition outside of Sweden and part of its strategy to build

Read More

New design and pack size for Duroferon

Avia Pharma has developed a more contemporary package for Duroferon on the Swedish market. The new design affects the 100-tablet blister, the 200-tablet blister and the 100-tablet plastic container.

Read More

Avia Pharma signs strategic agreement with Omega Pharma

Avia Pharma has entered into an in-licensing agreement with Omega Pharma for the following products; Duroferon, Ferro Duretter, Minifom, D-vitamin Olja ACO, D-vitamin Vatten ACO, Dunmedic Vitamin D-olja and Nix.Under the agreement Avia Pharma will handle all commercial aspects of the products.

Read More